4_M_1440049442.jpg?#)
Sarepta Therapeutics’ (SRPT) Sell Rating Reiterated at HC Wainwright
HC Wainwright restated their sell rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. SRPT has been the topic of a number of other reports. Wells Fargo & Company dropped their target price on Sarepta Therapeutics from $100.00 to $75.00 and set an “overweight” […]
HC Wainwright restated their sell rating on shares of Sarepta Therapeutics (NASDAQ:SRPT – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. SRPT has been the topic of a number of other reports. Wells Fargo & Company dropped their target price on Sarepta Therapeutics from $100.00 to $75.00 and set an “overweight” […]
